The 2002 Albert Lasker Award for Clinical Medical Research wasawarded to Willem J. Kolff and Belding H. Scribner for theirpioneering work in the development of hemodialysis.1,2 As theLasker Foundation noted in announcing the award, the developmentof renal hemodialysis "changed kidney failure from a fatal toa treatable disease, prolonging the useful lives of millionsof patients." This year also marks the 30th anniversary of thepassage of Public Law 92-603, which extended disability provisionsin Medicare coverage to those with end-stage renal disease (ESRD)who, regardless of age, were "deemed to be disabled." As 2002nears . . . [Full Text of this Article]
Scribner, B. H., Blagg, C. R., Friedman, E. A., Hoenich, N. A., Locatelli, F., Greene, T., Cheung, A. K., Eknoyan, G., the Hemodialysis (HEMO) Study Group, , Himmelfarb, J.
(2003). Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis. NEJM
348: 1491-1494
[Full Text]
Friedman, A. L.
(2003). Dialysis Dose and Membrane Flux in Maintenance Hemodialysis. AAP Grand Rounds
9: 33-34
[Full Text]